{"nct_id":"NCT02616029","title":"Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I","status":"COMPLETED","status_verified_date":"2020-07","start_date":"2015-12-17","start_date_type":"ACTUAL","primary_completion_date":"2018-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2019-07-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}